Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
December 2025—The CAP Artificial Intelligence Committee is developing a guide for laboratories on implementing AI, covering the entire machine learning life cycle. While laboratories can begin using AI now, they must ensure full validation, even for FDA-approved tools, due to potential biases and population drift.
December 2025—The absence of CDC surveillance data due to the government shutdown has created uncertainty about the severity and impact of the current respiratory virus season. While regional public health surveillance provides some insights, concerns remain about the potential for a severe season, exacerbated by vaccine hesitancy and changes in vaccine guidance.
December 2025—Northwestern Medicine Delnor Hospital piloted a program using drones for transporting patient samples and blood products between the hospital and cancer center. The program, using Valqari drones, achieved a 100% success rate in delivering 303 packages without any damage or temperature fluctuations.
December 2025—Massachusetts General Hospital implemented a clinical decision support solution to reduce unnecessary CBC and differential orders, particularly for inpatients. The solution involved an interruptive alert that targeted daily, more than daily, and as-needed orders, recommending alternative orders like CBCs without differentials.
December 2025—Pathologists will receive a 0.34% payment rate increase in the 2026 Medicare physician fee schedule, offset by a 2.5% efficiency adjustment. The College of American Pathologists (CAP) opposes this adjustment, arguing it inaccurately reflects the value of pathology and laboratory medicine and ignores the increasing complexity of medical practice.
December 2025—A 21-year-old male with a history of acute promyelocytic leukemia (APL) presented with symptoms suggestive of relapse. While standard tests like qRT-PCR and amplicon-based sequencing failed to detect the PML::RARA fusion, AMP NGS revealed an atypical bcr2 transcript with a novel breakpoint.
December 2025—A roundtable discussion on laboratory information systems (LIS) focused on the application of AI in lab workflows. Participants emphasized the need for AI to be used as a targeted tool to augment human work, highlighting its potential in streamlining documentation, coding, and data extraction.
Laboratories considering AI-driven workflows should first identify the specific problem they aim to solve and assess if simpler coding solutions are sufficient. While out-of-the-box AI solutions from vendors offer a lower barrier to entry, laboratories must ensure these solutions align with their workflows and validate them in their own environments.
Two new ADLM documents provide guidance on toxicology testing for emergency departments, replacing a 2003 guideline. The documents address test menus, turnaround times, and the importance of educating ED staff on assay limitations.
A recent article in Archives of Pathology & Laboratory Medicine emphasizes the importance of gender-inclusive care in cytopathology laboratories. The authors, members of the CAP Cytopathology Committee, identify four key areas for improvement: laboratory information systems and terminology, cervicovaginal Pap test screening, HPV testing, and anal Pap test screening. They advocate for gender-inclusive data entry, understanding changes from hormonal therapy, equitable access to HPV testing, and expanding anal Pap test screening infrastructure.
